This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhu, Y. Articles by Zheng, T. Search for Related Content PubMed PubMed Citation Articles by Zhu, Y. Articles by Zheng, T.

Period3 Structural Variation: A Circadian Biomarker Associated with Breast Cancer in Young Women

¹ Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut and ² University of Connecticut Health Center, Farmington, Connecticut

Requests for reprints: Yong Zhu, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06520. Phone: 203-785-4844; Fax: 203-737-6023. E-mail: yong.zhu{at}yale.edu

Circadian disruption has been indicated as a risk factor for breast cancer in recent epidemiologic studies. A novel finding in circadian biology is that genes responsible for circadian rhythm also regulate many other biological pathways, including cell proliferation, cell cycle regulation, and apoptosis. Therefore, mutations in circadian genes could conceivably result in deregulation of these processes and contribute to tumor development, and be markers for susceptibility to human cancer. In this study, we investigated the association between an exonic length variation in a circadian gene, Period3 (Per3), and breast cancer risk using blood samples collected from a recently completed breast cancer case-control study in Connecticut. There were 389 Caucasian cases and 432 Caucasian controls included in our analysis. We found that the variant Per3 genotype (heterozygous + homozygous 5-repeat alleles) was associated with an increased risk of breast cancer among premenopausal women (odds ratio, 1.7; 95% confidence interval, 1.0-3.0). Our finding suggests that the circadian genes might be a novel panel of potential biomarkers for breast cancer and worth further investigation.

Key Words: Breast Cancer • Circadian Gene • Period3

This article has been cited by other articles:

				E. S. O'Leary, E. R. Schoenfeld, R. G. Stevens, G. C. Kabat, K. Henderson, R. Grimson, M. D. Gammon, M. C. Leske, and for the Electromagnetic Fields and Breast Cancer o Shift Work, Light at Night, and Breast Cancer on Long Island, New York Am. J. Epidemiol., August 15, 2006; 164(4): 358 - 366. [Abstract] [Full Text] [PDF]

				Y. Zhu, T. Zheng, R. G. Stevens, Y. Zhang, and P. Boyle Does "Clock" Matter in Prostate Cancer? Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 3 - 5. [Abstract] [Full Text] [PDF]

				N. A. Nadkarni, M. E. Weale, M. von Schantz, and M. G. Thomas Evolution of a Length Polymorphism in the Human PER3 Gene, a Component of the Circadian System J Biol Rhythms, December 1, 2005; 20(6): 490 - 499. [Abstract] [PDF]

				D. E. Blask, G. C. Brainard, R. T. Dauchy, J. P. Hanifin, L. K. Davidson, J. A. Krause, L. A. Sauer, M. A. Rivera-Bermudez, M. L. Dubocovich, S. A. Jasser, et al. Melatonin-Depleted Blood from Premenopausal Women Exposed to Light at Night Stimulates Growth of Human Breast Cancer Xenografts in Nude Rats Cancer Res., December 1, 2005; 65(23): 11174 - 11184. [Abstract] [Full Text] [PDF]

				A. Jenkins, S. N. Archer, and M. von Schantz Expansion during Primate Radiation of a Variable Number Tandem Repeat in the Coding Region of the Circadian Clock Gene Period3 J Biol Rhythms, October 1, 2005; 20(5): 470 - 472. [PDF]

				J. Arendt Melatonin: Characteristics, Concerns, and Prospects J Biol Rhythms, August 1, 2005; 20(4): 291 - 303. [Abstract] [PDF]

				E. B. Klerman Clinical Aspects of Human Circadian Rhythms J Biol Rhythms, August 1, 2005; 20(4): 375 - 386. [Abstract] [PDF]